Table 3.
Parameter | Placebo (N = 1206) | Apabetalone (N = 1212) | P value |
---|---|---|---|
First hospitalization for heart failure, n (%) | 48 (4.0) | 29 (2.4) | 0.03 |
HR (95% CI) | 0.59 (0.38–0.94) | ||
Total hospitalizations for heart failure, n | 70 | 35 | 0.01 |
HR (95% CI) | 0.47 (0.27–0.83) | ||
Cardiovascular death, n (%) | 55 (4.6) | 45 (3.7) | 0.28 |
HR (95% CI) | 0.81 (0.54–1.19) | ||
First hospitalization for heart failure or cardiovascular death, n (%) | 94 (7.8) | 69 (5.7) | 0.04 |
HR (95% CI) | 0.72 (0.53–0.98) |
Cardiovascular events in patients treated with apabetalone or placebo